AIMEE KILGO: Open Payments
NPI 1760807119 · CENTRE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,294 in 74 payments from 17 companies in 2025. Trend: 2023 $1,100 · 2024 $3,064 · 2025 $1,294
Food & beverage: $1,294
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $279 |
| AstraZeneca Pharmaceuticals LP | 11 | $235 |
| GlaxoSmithKline, LLC. | 13 | $161 |
| Amgen Inc. | 5 | $81 |
| PFIZER INC. | 5 | $81 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $76 |
| Astellas Pharma US Inc | 2 | $64 |
| Novo Nordisk Inc | 3 | $62 |
| Axsome Therapeutics, Inc. | 3 | $53 |
| Lilly USA, LLC | 2 | $44 |
Products named: AIRSUPRA, TRELEGY ELLIPTA, VRAYLAR, UBRELVY, QULIPTA, NURTEC ODT, TRINTELLIX, Veozah.
Industry payments across AL — which companies pay providers there.
